Talon Therapeutics, Inc.
Records under this name other than patents Talon Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 10 of 10 · Back to Talon Therapeutics, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,815,953 | Formulations of Vitamin K Analogs for Topical Use Lapsed on the fee record Ended Aug 26, 2026 · High confidence | Lapsed on the fee record | Ended Aug 26, 2026 | High confidence |
| US 9,801,874 | Method for the Preparation of Liposome Encapsulated Vincristine for Therapeutic Use Formerly held Lapsed on the fee record Ended Oct 31, 2025 · High confidence | Lapsed on the fee record | Ended Oct 31, 2025 | High confidence |
| US 7,244,450 | Compositions and Methods for Treating Lymphoma Formerly held Term ended Ended no later than Mar 6, 2022 · Low confidence | Term ended | Ended no later than Mar 6, 2022 | Low confidence |
| US 7,311,924 | Compositions and Methods for Treating Cancer Term ended Term ended Nov 14, 2021 · Medium confidence | Term ended | Term ended Nov 14, 2021 | Medium confidence |
| US 7,060,828 | Liposomal Camptothecins and Uses Thereof Term ended Term ended Jun 29, 2021 · High confidence | Term ended | Term ended Jun 29, 2021 | High confidence |
| US 7,244,448 | Liposomal Antineoplastic Drugs and Uses Thereof Term ended Term ended Jun 29, 2021 · High confidence | Term ended | Term ended Jun 29, 2021 | High confidence |
| US 7,452,550 | Liposomal Antineoplastic Drugs and Uses Thereof Term ended Term ended Jun 29, 2021 · High confidence | Term ended | Term ended Jun 29, 2021 | High confidence |
| US 7,887,836 | Compositions and Methods for Treating Lymphoma Formerly held Term ended Ended no later than Apr 5, 2021 · Low confidence | Term ended | Ended no later than Apr 5, 2021 | Low confidence |
| US 7,247,316 | Compositions and Methods for Treating Lymphoma Formerly held Term ended Term ended Sep 28, 2020 · Medium confidence | Term ended | Term ended Sep 28, 2020 | Medium confidence |
| US 6,723,338 | Compositions and methods for treating lymphoma Formerly held Term ended Term ended Mar 31, 2020 · USPTO record | Term ended | Term ended Mar 31, 2020 | USPTO record |